Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Oral betamethasone mini-pulses effectively treat moderate to severe alopecia areata with manageable side effects.

Both fat-derived stem cells and platelet-rich plasma are effective and safe for hair loss, but stem cells give better results with more side effects.

The inhibitor affects androgen metabolism but not ovarian function.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Oral JAK inhibitors help regrow hair in alopecia areata with manageable side effects.

Cross-section trichometry is an accurate method to measure hair loss and growth.

Ritlecitinib effectively regrows hair in severe alopecia areata, especially in adolescents.

Recent advances in hair loss treatments show significant progress.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

The treatment is safe and very effective for hair growth in Asian men with minimal side effects.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

A natural extract-based hair growth product was developed and showed promise in preliminary tests.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

The treatment increased hair follicle counts and is potentially effective for male hair loss without serious side effects.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

PRP might help with hair growth, but the evidence is weak.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

The treatment improved hair growth and was well-received without side effects.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

The Rigenera method improved hair thickness and reduced hair loss in patients.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Both treatments help with hair regrowth in alopecia areata, but azathioprine has milder side effects than betamethasone.